Live Breaking News & Updates on புற்றுநோய் நோயெதிர்ப்பு ஆராய்ச்சி

Stay updated with breaking news from புற்றுநோய் நோயெதிர்ப்பு ஆராய்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Portonbio announced strategic cooperation with KAEDI to accelerate the R&D and production of CAR-T drugs


Share this article
SUZHOU, China, June 2, 2021 /PRNewswire/
On May 31, 2021, Porton Biologics Ltd. (hereinafter referred to as Portonbio) announced a strategic cooperation with Nanjing KAEDI Biotech, Inc. (hereinafter referred to as KAEDI). Portonbio will offer CMC services for KAEDI s CAR-T cell therapies with its end-to-end CDMO platform for gene and cell therapies to help accelerate their development process.
According to the agreement, Portonbio, as an exclusive CDMO partner, will provide KAEDI with CMC services for multiple CAR-T projects
,
 including the process development and manufacturing of plasmids, viral vectors and CAR-T cells and IND filling (CMC part) support services. The indication of the first project of our collaboration, KD-025 CAR-T, is liver cancer and glioma. The results of its preclinical research have been published in the leading international journal of tumor immunotherapy and ASCO (American Society of Clinical Oncology). At pres ....

Nianfeng Ju , Porton Biologics , Hongjiu Dai , Cancer Immunology Research , Porton Pharma Solutions Ltd , Porton Biologics Ltd , Pharma Solutions , Cell Therapeutics , Quality Management , போர்‌டந் உயிரியல் , புற்றுநோய் நோயெதிர்ப்பு ஆராய்ச்சி , போர்‌டந் பார்மா தீர்வுகள் லிமிடெட் , பார்மா தீர்வுகள் , செல் சிகிச்சை , தரம் மேலாண்மை ,

Study discusses impact of chemotherapy on immune cells | News


2 hours ago
Apr 14, 2021, 04:30AM ISTSource: ANI
The findings of recent research from Queen Mary University of London revealed novel insights into the effects of chemotherapy on the tumour microenvironment. The study, published today in Cancer Immunology Research, a journal of the American Association for Cancer Research, found that chemotherapy enhances the antitumor actions of immune cells within the TME and their ability to support immune responses against cancer. Cancers are not just a mass of cancerous cells but are rogue organs made up of many different cell types, including cells that form connective tissue and blood vessels, and immune cells. These non-cancerous cells have been recruited and corrupted by cancer to help it grow and spread, and constitute what is known as the TME. When treating cancer cells with chemotherapy, the cells within the TME are also impacted and previous research has shown that chemotherapy may activate immune cells within the TME to fight ....

United States , Fran Balkwill , Cancer Immunology Research , American Association For Cancer Research , Queen Mary University Of London , Queen Mary University , American Association , Cancer Research , Professor Fran Balkwill , Ovarian Cancer , Nti Tumour Action , ஒன்றுபட்டது மாநிலங்களில் , புற்றுநோய் நோயெதிர்ப்பு ஆராய்ச்சி , அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி , ராணி மேரி பல்கலைக்கழகம் ஆஃப் லண்டன் , ராணி மேரி பல்கலைக்கழகம் , அமெரிக்கன் சங்கம் , புற்றுநோய் ஆராய்ச்சி ,